President Donald Trump didn’t achieve significant reductions in drug prices during his first term, yet this time might be different. The President’s proposal, of “most favored nation” (MFN) policy, tying U.S. drug prices to the lowest prices paid by other developed countries, might make it this time as the rules have changed. Last time, a […]
